Add Company
Join Now

Clovr Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • Clovr has 33 Employees.(i)
  • Clovr grew their employee count by -3% last year.

Clovr's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
Marketing DirectorReveal Email/Phone
3
Marketing DirectorReveal Email/Phone
4
Laboratory ManagerReveal Email/Phone
5
Compliance ManagerReveal Email/Phone
6
Distribution SpecialistReveal Email/Phone
7
Account ExecutiveReveal Email/Phone
8
Production LeadReveal Email/Phone
9
Laboratory TechnicianReveal Email/Phone
10
Brand AmbassadorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M7423%N/AN/A
#2
$3.5M3043%N/AN/A
#3
N/A11212%N/AN/A
#4
N/A2321%N/AN/A
#5
N/A2N/AN/AN/A
#6
$35M11622%N/AN/A
#7
N/A3233%N/AN/A
#8
N/A33-3%N/AN/A
#9
N/A2033%N/AN/A
#10
N/A740%N/AN/A
Add Company

What Is Clovr?

Headquartered in Kansas City, Clovr is a cannabis-infused product manufacturer that believes in safe, consistent, and quality cannabis products for Missouri's medical marijuana patients. Being the extractor, infuser, and seller of our own products ensures patients are getting exactly what they are reading on the label - no chemicals, no funny business. Clovr believes there's a consumption method for every type of person and we are happy to find what best fits you and your lifestyle. We offer cannabis-infused chocolate bars, gummies, vape pens, concentrates, sodas, capsules, and many more products for whatever your consumption method you prefer. Combating the stereotype, we believe cannabis can be a part of your life without becoming your life. If you want to see these products in your dispensaries contact us today at info@clovrcannabis.com.

keywords:N/A

N/A

Total Funding

33

Number of Employees

N/A

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M330%N/A
#2
$7M3314%N/A
#3
$11M333%N/A
#4
$5.2M3310%N/A
#5
$10M3318%N/A